World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
71
Citations
17374
World Ranking
20001
National Ranking
9962

Overview

Jerry L. Spivak is affiliated with Johns Hopkins University School of Medicine in the United States. Their research spans multiple fields, primarily focusing on Medicine and Biochemistry, Genetics, and Molecular Biology. Within these broader disciplines, their work extensively covers Genetics, Hematology, Molecular Biology, Immunology, and Rheumatology.

The main research topics associated with Jerry L. Spivak include:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Kruppel-like factors research
  • Chronic Myeloid Leukemia Treatments
  • Eosinophilic Disorders and Syndromes
  • Immunotherapy and Immune Responses
  • Hemoglobinopathies and Related Disorders

Jerry L. Spivak has contributed to key publications in prominent journals. Recent papers include:

  • "Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden," 2020, Blood Advances
  • "HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression," 2022, Blood
  • "Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia vera," 2020, PLoS ONE
  • "The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN," 2021, Frontiers in Oncology
  • "Advances in polycythemia vera and lessons for acute leukemia," 2021, Best Practice & Research Clinical Haematology

Their frequent coauthors include:

  • Alison R. Moliterno
  • Leslie Cope
  • Linda Resar
  • Jung-Hyun Kim
  • Liping Li

Jerry L. Spivak has published multiple articles in specific venues, notably:

  • Blood
  • Cancer Research
  • Blood Advances
  • PLoS ONE
  • Frontiers in Oncology

Best Publications

  • Commentary on and reprint of EPIC (Evaluation of 7E3 for the Prevention of Ischemic Complications) Investigators, The, Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty, in New England Journal of Medicine (1994) 330:956–961

    M Lichtman;J Spivak;L Boxer;S Shattil

  • Decreased erythropoietin response in patients with the anemia of cancer.

    Carole B. Miller;Richard J. Jones;Steven Piantadosi;Martin D. Abeloff

  • Polycythemia vera: myths, mechanisms, and management.

    Jerry L. Spivak

  • Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders

    Zhaohui Ye;Huichun Zhan;Prashant Mali;Prashant Mali;Sarah Dowey

  • American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer

    J. Douglas Rizzo;Melissa Brouwers;Patricia Hurley;Jerome Seidenfeld

  • Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.

    A R Moliterno;W D Hankins;J L Spivak

  • Hematologic abnormalities in the acquired immune deficiency syndrome

    Jerry L. Spivak;Bradley S. Bender;Thomas C. Quinn

  • Commentary on and reprint of Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG, Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma, in Lancet (1991) 338:1175–1176

    M Lichtman;J Spivak;L Boxer;S Shattil

  • Commentary on and reprint of Nowell PC, Hungerford DA, A minute chromosome in human chronic granulocytic leukemia, in Science (1960) 132:1497

    M Lichtman;J Spivak;L Boxer;S Shattil

  • Serum immunoreactive erythropoietin in HIV-infected patients

    Jerry L. Spivak;David C. Barnes;Edward Fuchs;Thomas C. Quinn

  • The in vivo metabolism of recombinant human erythropoietin in the rat.

    Jerry L. Spivak;Beth B. Hogans

  • Immunoablative High-Dose Cyclophosphamide without Stem-Cell Rescue for Refractory, Severe Autoimmune Disease

    Robert A. Brodsky;Michelle Petri;B. Douglas Smith;Eric J. Seifter

  • American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer

    J. Douglas Rizzo;Melissa Brouwers;Patricia Hurley;Jerome Seidenfeld

  • Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors.

    Thomas S. Kickler;Jerry L. Spivak

  • Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation.

    M P Carroll;J L Spivak;M McMahon;N Weich

  • Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia

    Damiano Rondelli;Giovanni Barosi;Andrea Bacigalupo;Josef T. Prchal

  • Polo-like Kinase Is a Cell Cycle-regulated Kinase Activated during Mitosis

    Ryoji Hamanaka;Mark R. Smith;Patrick M. O'Connor;Sharon Maloid

  • The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis and primary myelofibrosis: an alternative proposal

    Jerry L. Spivak;Richard T. Silver

  • The mechanism of action of erythropoietin

    Jerry L. Spivak

  • Erythropoietin is both a mitogen and a survival factor.

    JL Spivak;T Pham;M Isaacs;WD Hankins

Frequent Co-Authors

Zhizhuang Joe Zhao
Zhizhuang Joe Zhao University of Oklahoma Health Sciences Center
Richard T. Silver
Richard T. Silver Cornell University
Thomas C. Quinn
Thomas C. Quinn Johns Hopkins University
Linzhao Cheng
Linzhao Cheng Chinese Academy of Sciences
Zhaohui Ye
Zhaohui Ye US Food and Drug Administration
Saul J. Sharkis
Saul J. Sharkis Johns Hopkins University School of Medicine
Michael A. McDevitt
Michael A. McDevitt Johns Hopkins University
Takako Yokozawa
Takako Yokozawa University of Toyama
Fumitake Gejyo
Fumitake Gejyo Niigata University
Chi V. Dang
Chi V. Dang University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up diverse pathways beyond traditional Medical Doctor (MD) programs. For students aiming to enter healthcare more quickly or advance their careers, online nursing degrees have become increasingly popular and accessible.

Flexible programs like a nursing degree online allow you to gain foundational clinical skills from anywhere. Many students also consider specialized routes, such as progressing into nurse practitioner roles via the cheapest online nurse practitioner programs to meet growing healthcare demands.

For registered nurses seeking higher credentials, the cheapest rn to bsn program online enables RNs to obtain a Bachelor of Science in Nursing, boosting both skills and job opportunities. Those aiming for leadership or academic positions may opt for the cheapest online dnp programs, which provide doctoral-level nursing education in a flexible format.

Online healthcare degrees deliver affordability, convenience, and access, making them an excellent alternative or complement to traditional medical pathways in the USA.

Best Scientists Citing Jerry L. Spivak

Trending Scientists